CPSA BRASIL 2017

The Sanitary Regulation as a Strategy for the Development of Products and Services in the Pharmaceutical Chain

Organizing Committee

Program Chair
Natália Bellan Inteligência Sanitária Brasil

Douglas Andrade SCIEX Brasil
Gabriel Araújo University of São Paulo Brasil
Gabriela Barreiro Eurofarma Brasil
Rafael Barrientos Eurofarma Brasil
Natália Bellan Inteligência Sanitária Brasil
Gisela Bellinello Agilent Technologies Brasil
Chad Briscoe PRA Health Sciences USA
Jair Calixto Sindusfarma Brasil
Mateus Campos SCIEX Brasil
Dulce Casarini Universidade Federal de São Paulo Brasil
Marc Chalom Thermo Fisher Scientific Brasil
Paul Corcoran McKinley Scientific USA
Marité Faria Amgen Brasil
Alana Figueiredo SCIEX Brasil
Saul Fink Bristol-Myers Squibb USA
Jane Finzi Thermo Fisher Scientific Brasil
Larissa Fontes GC2 Brasil
Miller Freitas Aché Laboratórios Farmacêuticos S.A Brasil
Roberto Gois GC2 Brasil
Caroline Green Waters Technologies Do Brasil Brasil
Thiago Mares Guia Bionovis Brasil
Mark Hayward ITSP Solutions USA
Lucinda Hittle Merck USA
Ivan Jonaitis Agilent Technologies Brasil
Carla Juliani US Pharmacopeia Brasil
Carlos Kiffer GC2 Brasil
Rick King PharmaCadence USA
Daniel Lebre CEMSA Laboratories Brasil
Mike Lee Milestone Development Services USA
Ken Lewis OpAns USA
Lídia Lima Federal University of Rio de Janeiro Brasil
Mauricio Magalhães EMS Brasil
Vanda Magalhães Eurofarma Brasil
Carla Marshall-Waggett New Objective USA
Helio Martins SCIEX Brasil
Cristina Mendes Instituto Nacional da Propriedade Industrial Brasil
Marcelo Moreira ANVISA Brasil
Lauro Moretto Academia Nacional de Farmácia Brasil
Michael Murgu Waters Technologies Do Brasil Brasil
Carolina Nakai SCIEX Brasil
Viviane Nascimento Thermo Fisher Scientific Brasil
Shane Needham Alturas Analytics USA
Randy Nelson Arizona State University USA
José Emílio Neto Quintiles Brasil
Kátia Pastre MAGABI Brasil
Adriano Peron SCIEX Brasil
Paula Ribiero Shimadzu Brasil
Renato Ribeiro Accutest Research Laboratories (I) Pvt. Ltd. Brasil
Camille Rodrigues da Silva PHARMAGENIX Brasil
Renato Romano US Pharmacopeia Brasil
Cristina Ropke Phytobios Brasil
Ana Ruenis ABRACRO Brasil
Nalini Sadagopan Agilent Technologies USA
Daniel Saidemberg Shimadzu Brasil
Gustavo Santos ANVISA Brasil
Priscila Scheinberg Orygen Biotecnologia Brasil
Henrique Silva US Pharmacopeia Brasil
Suéllen Silva Aspen Farmacêutica Brasil
Martin Steel McKinley Scientific USA
Leonardo Teixeira Instituto de Ciências Farmacêuticas Brasil
Phillip Timmerman Janssen Pharmaceuticals Belgium
Gary Valaskovic New Objective USA
Peter van Amsterdam Abbott Netherlands
Naidong Weng Janssen Research & Development USA
José Xavier Agilent Technologies Brasil
Nathan Yates University of Pittsburgh USA